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Objectives.
The aim of this study was to determine whether
patients with ventricular arrhythmias In the absence of cod inary
artery die also have abnormalities in sympathetic innerva
.
two,
Background. We have previously shown by cardiac sympa-
thetic scintigraphy using lodine-123-metaiodobenzylguanidine
(1.1123-MIlG) that patients with ventricular tachycardla after
myocardial Infarction have regional cardiac sympathetic denerva .
don, It Is not known whether patients with ventricular tachycar-
dia In the
absence of coronary artery disease also have regional
cardiac sympathetic denervation,
Methods, We performed cardiac 1.123-MIBG and thallium-201
single-photon emission computed tomographic (SPELT) scans at
rest In 18 patients (mean age 47 t 18 years) with cardiomyopath3
(n = 6), left ventricular hypertrophy (a = 1), valvular disease
(n = 2) or a structurally normal heart (n = 9) who presented with
monomorphic (n = 15) or polymorphic (n = 3) ventricular
tachycardla, These scans were compared with scans in 12 control
patients without ventricular tachycardia (mean age 30 t 17 years)
who had cardiomyopathy (a = 3) or a structurally normal heart
Sympathetic innervation to the heart modulates arrhythmo-
genesis. Reduction of sympathetic input to the left ventricle
(by left stellectomy) in patients with the long QT interval
syndrome exerts antiarrhythmic effects (1) . whereas sympa-
thetic stimulation enhances arrhythmogenesis in many ani-
mal models (23) .
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ELECTROPHYSIOLOGY
(n = 9). Cardiac sympathetic denervation was defined as myocar-
dial areas having thallium uptake with reduced or absent 1 .123-
M sc1 uptake.
Results
. Twelve (67%) of 18 patients with ventricular tachy-
cardla had regional cardiac sympathetic denervation compared
with 1(8%) of 12 patients who did not have ventricular tachycar-
dia (p = 0 .002). In the nine patients with a structurally normal
heart and ventricular tachycardia, five (55%) patients had re-
gional cardiac sympathetic denervation comps with zero of
nine control patients with a structurally normal heart (p = 0 .029) .
Five patients underwent right ventricular radio uency ablation
for ventricular tachycardia, and sympathetic denervation was
adjacent to the ablation site in one of these patients .
Conclusions . Patients with ventricular tachycardia in the ab-
sence of coronary artery disease have abnormal cardiac sympa-
thetic innervation detectable by cardiac sympathetic scintigraphy .
The role of regional cardiac sympathetic denervation in arrhyth-
mogenesis remains to be determined .
tJ Am Coll Cardiol 1993,22:1344-53)
Sympathetic nerves to the ventricle lie in the subepicar-
dium, penetrating intramurally to innervate the endocar-
dium. Phenol painted on a discrete area in the epicardium
interrupts both afferent and efferent sympathetic function,
effectively denervating myocardium downstream from the
injured area (4--6) . Similarly, experimental transmural infarc-
tion in a canine model interrupts sympathetic nerve function,
which then causes sympathetic denervation in viable myo-
cardium apical to the infarct (5,7-10) . The subsequent den-
ervation supersensitivity to circulating catecholamines (11)
has been implicated in the pathogenesis of arrhythmias
(12,13) .
To understand further the presence and potential impor-
tance of regional cardiac sympathetic denervation, noninva-
sive imaging of the cardiac sympathetic nervous system can
be performed by single-photon emission computed tomogra-
phy (SPELT) after administration of iodine-I23-labeled
metaiodobenzylguanidine (I-123-MIBG) (14-16) . The latter,
a guanethidine derivative, is a radiolabeled analog of norepi-
nephrine and is taken up by the postganglionic presynaptic
sympathetic nerve terminals with the same uptake mecha-
0735-1097!93/56 .011
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nism used for norepinephrine (17) . Scintigraphy with this
agent has been shown in both dogs (18,19) and humans
(20-22) to be capable of locaiLing regional defects in cardiac
sympathetic innervation (17-720) In a canine model after
myocardial infarction, Minardo et al . (19) correlated the
presence of sympathetic denervation detected by 1-123-
MIBG scintigraphy with sympathetic denervation detected
by electrophysiologic techniques .
Sympathetic denervation has also been demonstrated
scintigraphically in patients after myocardial infarction (20-
22) and in patients with cardiomyopathy (23,24) or the long
QT syndrome (25) . Stanton and colleagues (20) showed that
patients with a history of myocardial infarction and ventric-
ular tachycardia have a high prevalence of sympathetic
denervation . They proposed a role for sympathetic denerva-
tion in the pathogenesis of ventricular tachycardia in patients
after myocardial infarction (13) .
Because the pathogenesis of ventricular tachycardia in
patients without coronary artery disease, particularly in
those with a structurally normal heart, remains unclear, we
speculated that abnormalities in cardiac sy- :-)athctik.: inner-
vation may be critical in the pathogenesis of ventricular
arrhythmia. The purpose of this study was to determine
whether patients with ventricular arrhythmias in the absence
of coronary artery disease also have abnormalities in sym-
pathetic innervation .
Methods
Study patients . Twenty patients with documented ven-
tricular arrhythmias in the absence of coronary artery dis-
ease underwent SPECT imaging after injection of 1-123-
MIBG. Inclusion criteria included ability to give informed
consent, absence of coronary artery disease as detected by
cardiac catheterization, echocardiography or exercise test-
ing alone or in combination . Exclusion criteria included
receiving medications known to interfere with 1-123-MIBG
uptake, such as calcium channel blocking agents, beta-
agonist drugs or major tranquilizing agents (26) . Two of the
20 patients who had no cardiac I- 123-MIBG uptake and were
subsequently found to be receiving medications known to
inhibit I-123-MIBG uptake, were excluded from subsequent
analysis. Clinical characteristics in the remaining 18 patients
comprising Group I are shown in Table 1. Patients were
Judged as having a structurally normal heart if they had
normal left ventricular dimensions, normal left ventricular
systolic function and absent right ventricular abnormalities,
as determined by echocardiography and cardiac catheteriza-
tion . In addition, all patients with a structurally normal heart
except for Patient 5 had normal thallium scans at rest .
Patient 5 had an inferior thallium defect but was still included
among those patients with a structurally normal heart be-
cause he had normal results on echocardiography and car-
diac catheterization including left ventricular angiography .
Patients with mitral valve prolapse without mitral regurgita-
tion (Patient 7), the congenital long QT syndrome (Patient 8)
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and the acquired long QT syndrome (Patient 9) were consid-
ered to have a structurally normal heart
. Fourteen of these
18 patients had coronary arteriographic findings confirming
the presence of normal coronary arteries . The other four
patients were women (26, 29, 40, and 67 years old, respec-
tively) with no history suggestive of coronary artery disease .
Two of these four patients had normal findings on exercise
stress tests and echocardiography, one patient had a normal
exercise stress test result with echocardiographic evidence
of decreased left ventricular systolic function without re-
gional wall motion abnormalities and one had normal
echocardiographic findings and did not undergo exercise
stress testing (Table 1) . No patient in this group or the
control group had diabetes mellitus or any diseases known to
be associated with neuropathies .
Control group. The control patients (Gioup 11) were 12
patients who underwent I-123-MIBG imaging and had both
no evidence of coronary artery disease and no history of
documented ventricular arrhvthmias . Four of the 12 patients
were normal, healthy volunteers with no known medical
problems. Of the remaining eight patients, three showed no
evidence of coronary artery disease by coronary arteriogra-
phy ; three others (11, 12 and 19 years old, respectively, and
all within one family) had the diagnosis of familial hypertro-
phic cardiomyopathy with a family history of sudden death,
and two other patients were women (23 and 46 years old,
respectively) with no history of coronary artery disease and
with normal findings on echocardiography and exercise
stress testing . None of these 12 patients had defects on
their thallium scans . Eight had no presenting symptoms
(Table 1), but four had episodes of palpitation ; electrophys-
iologic studies in these four failed to induce ventricular
tachycardia .
Thallium-201 scintigraphy . A thallium-201 scinttgram at
rest was performed in 27 of the 30 patients ; 3 others ( I
patient in Group I and 2 patients in Group 11) underwent
thallium-201 scintigraphy as part of an exercise test . The
protocol for the thallium-201 scans at rest was as follows :
Patients were given an intravenous injection of 2 .1 to 2 .9
mCi of thallium-201 . Twenty to 40 mia after injection,
cardiac images were obtained using 20% energy windows
centered over the thallium-201 photopeak (80 keV) on a
commercially available gamma camera equipped with a low
energy, all-purpose collimator. Tomographic images were
obtained on a rotating camera from right anterior oblique to
left anterior oblique in an 180° arc at 3° per step (20 s per
frame) yielding 60 sequential images . Single-photon emission
computed tomographic images were then reconstructed us-
ing a 0.35/8 Butterworth filter to display between 8 and 16
tomographic slices through the short, vertical long and
horizontal long axes. For the three patients who underwent
thallium-201 scintigraphy in conjunction with treadmill exer-
cise tasting, the protocol was modified as follows
: The
patients were given an intravenous injection of 2 .5 to 2 .9 mCi
of thallium-201 1 min before completion of exercise
. Images
were obtained in a manner similar to that described for the
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Tape 1
. Clinical Charrtcteristics of Patients
rest study immediately after exercise (stress) and 4 h later
(redistribution). Only the redistribution images were used to
compare with the I-123-MIBG images .
Iodine-13,3-me uanidine Imaging. High pu-
rity I-123-MIBG was synthesized according to previously
published criteria (27) at a specific activity of 7 to 10 mCi/mg
.
Patients received an injection of 2 .6 to 6.1 mCi of 1-123-
MIBG after completion of the thallium scan (at rest or
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''Patients 19 to 22 were the four normal healthy volunteers, tVentricular tachycardia only inducible with isoproterenol
. #Spontaneous ventricular tachycardia
with isoproterenol . §Patients 28 to 30 were from the same extended
family. AR = aortic regurgitation ; bx = by biopsy ; CA = coronary arteries ; CMP
cardiomyopathy ; [3CM = dilated cardiomyopathy
; EPS = electrophysiologic study; F = female; HCM = hypertrophic cardiomyopathy
; Indet = indeterminate
;
irreg
-
irregularities ; L QT = long
QT; LV = left ventricle; LV dil = left ventricular dilation
; LVH = left ventricular hypertrophy ; M = male ; MR = mitral
regurgitation
; MVP = mitral valve prolapse ; Ni = noninducible
; NJ -- normal ; Palp = palpitation : PMVT = polymorphic ventricular tachycardia ; pt = patient ;
SNH
a
structurally normal heart
; TL-MIBG = thallium-201 imaging with iodine-I23-metaiodobenzylguanidine ; Vfib = ventricular fibrillation ; Vflut = ventricular
Gutter
; VT = ventricular tachycardia, VTNS = nonsustained ventricular tachycardia .
redistribution) or on a separate day from the thallium scan .
Images were obtained between 2 and 4 h after administration
of 1-123-MIBG to allow for the extraneurovesicular clear-
ance of I-123-MIBG uptake (28) . The technique lot obtaining
cardiac images after I-123-MIBG administration was similar
to the protocol described for the thallium-201 images except
for the 20% energy window, which was centered over the
I-123-MIBG photopeak (159 keV) .
Pt
No-
Age (yr)I
Gender
Presenting
Symptom
or
Arrythmia
Cardiac
Disease
Echo al . iographic
Results
Result of
Stress
Test
Cardiac
Catheterization
Results TL-MIBG Results
EPS
Results
Group I
1 50IM
VTNS SNH NJ
NJ NJ CA, NJ LV Denervation, anteroseptal VTNS
2
24/M VT SNH
NJ NJ NJ CA, NJ LV NJ
VTt
3 72/M VT
SNH NJ
NJ CA Denervation, posterolateral VT
4 69/F
VTNS SNH Ni
and inferoapical
Denervation, inferior VTNS
5
44/M VT SNH NJ
NJ CA, NJ LV
Denervation, anterolateral VTNSt
6 61/M VT SNH
Ni NJ NJ CA, NJ LV NJ
VT
7 27161 VT
SNH . MVP NJ
NJ CA, NJ LV
NJ
VT
8 26/F PMVT
MVP
SNH. l. NJ NJ
PMVT/Vflb
9 40/F F'MVT
QT
SNH, L NJ NJ
Denervation, anteroseptal Vliut
10 70/M VT
QT
I.VH LVH NJ CA 17 enervation, inferior and
V'ft
i 1 79/F VT MR, LV LV dil, MR
NJ CA, MR
lateral
Denervation . inferior VT
12 31/M VT
dii
AR AR NJ NJ CA Denervation, apical VT
13 36/F VT CMP/bx NJ NJ NJ CA
Ni VTNS
14 45/F VT DCM
DCM, LVdil
CMP/bx
NJ CA Denervation, inferior VT
is 47/M VTNS DCM DCM Ni NJ CA, DCM Denervation, inferior Ni
16 27/M VT DCM IBC NI CA Denervalion, inferoapical VT
17 29/F VT DCM DCM NJ NJ
VTtf
18 67/M PMVT DCM DCM NJ CA, DCM Denervation . inferoapical Ni
Group 11
19* 211M None SNH NJ
20 26/M None SNH NJ
21* 37/M None SNH NJ
22" 4UM None SNH NJ
23 46/F
Paip SNH Ni NJ NJ Ni
24 23/F Palp SNH
NJ
Ni
NJ Ni
25 66/F None SNH NJ Indet
Minor irreg NJ
26
39IF Palp SNH NJ NJ CA NJ Ni
27 16/F
UP SNIT, MVP NJ NJ CA NJ Ni
281 1/M
None
MVP
HCM§ 11CM NJ Denervation, inferior
291 12/F None
HCM§ HCM NJ NJ
301 II/IF
None HCM§
HCM NJ NJ
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TL 201
WTUBG
0
Fit-are 1 . This vertical long-axis schematic of a single-photon emis-
sion computed tomographic (SPECT) image shows an inferior
matched defect between thallium-201 (TL 201) and iodine-123-
metaiodobenzy1guanidine (I-123-MIBG) images (single arrow) and
an apical mismatch (double arrow) between TL-201 (normal perfu-
sion) and 1-123-MIBG (defect) consistent with sympathetic dener-
vation of the apex .
Interpretations of the 1-123 . MIBG and thallium-201 car-
diac images were performed by nuclear medicine physicians
(R .W .B . and H .N .WJ who were unaware of the patients'
clinical history
. Sympathetic denervation was defined to be
present when areas showed "thallium/MIBG mismatch,"
that is, areas of myocardium demonstrated perfusion on the
thallium-201 scan but had reduced or absent uptake on the
1-123-MIBG scan (Fig. 1). Iodine- I 23-metaiodobenzyiguani-
dine uptake was compared with the point of maximal MIBG
uptake within the heart ; therefore, reduced MIBG uptake in
one area of myocardium was relative to the reference point
that had maximal uptake . To check for reproducibility, the
patients' scans were interpreted on 2 separate days (from a
few weeks to several months apart) with respect to the
presence or absence of sympathetic denervation . In cases of
discordant interpretations, differences were resolved by
agreement between the nuclear medicine physicians who
still had no knowledge of patient data .
Electrophysiologic testing. All 18 patients in Group 1 and
4 of the 12 patients in Group 11 underwent electrophysiologic
testing in the absence of antiarrhythmic drugs according to a
previously described ventricular stimulation protocol (29) .
Briefly, ventricular stimulation was performed by the intro-
duction of up to three premature ventricular stimuli at
decreasing intervals, that scanned diastole to the point of
ventricular refractoriness while pacing from two right ven-
tricular sites and using at least two different drive train cycle
lengths . In Patients 2, 5 and 17, ventricular tachycardia was
induced after isoproterenol infusion. Standard definitions
were used for sustained, nonsustained and polymorphic
ventricular tachycardia (30) . Polymorphic ventricular tachy-
cardia induced in two patients was judged to be clinically
relevant because it reproduced the patients' clinical arrhyth-
mias .
Ventricular tachycardia mapping . Five patients under-
went successful radiofrequency ablation treatment for their
ventricular tachycardia and had detailed electrophysiologic
mapping of the origin of the ventricular tachycardia (31) . The
sites of ventricular tachycardia foci in these five patients
MITRANI ET AL
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were identified fluoroscopically and then compared with
sites of regional sympathetic denervation identified on the
SPECT scans to determine the proximity of the ventricular
tachycardia focus to the area of sympathetic denervation .
Patients 1, 5 and 7 had 1-123-MIBG scintigraphy within 2
days after radiofrequency ablation of the ventricular tachy-
cardia focus, and Patients 2 and 12 had 1-123-MIBG scintig-
raphy before ablation .
94,a!90cs. The Fisher exact tee,, was used to compare
categoric variables and the unpaired t test was used to
compare continuous data between the two groups . A p value
< 0.05 was considered significant .
Results
The clinical features of the 18 study patients (Group 1)
and 12 control patients (Group 11) are shown in Table 1 . The
mean age of the study patients (48 ± 19) exceeded the mean
age of the control patients (30 ± 16, p = 0 .015) . However,
for the subgroup of patients with a structurally normal heart,
the mean ages between the study group (46 ± 18) i ad the
control group (35 ± 16) did not differ significantly (p = NS) .
The presenting arrhythmia for the study group was mono-
morphic sustained ventricular tachycardia (n = 12), mono-
morphic nonsustained ventricular tachycardia (n = 3) or
polymorphic ventricular tachycardia (n = 3) . The cardiac
diagnoses for these 18 patients were cardioinyopathy (r, =
6). left ventricular hypertrophy (n = I), mitral regurgitation
with left ventricular dilatation (n = 1), bicuspid aortic valve
with mild aortic regurgitation (n = 1) and structurally normal
heart (n = 9) . All patients with a structurally normal heart
and Patients 10 to 13 had normal left ventricular systolic
function, Of the nine patients with a structurally normal
heart, one had mitral valve proiapse and two had a long QT
(duration 480 and 550 ms, respectively) before their arrhyth-
mia .
Of the 12 control patients (Group 11), 3 had hypertrophic
cardiomyopathy and 9 had a structurally normal heart . One
of the latter nine patients had mitral valve p , -olapse .
Results of iodine-123 metaiodobenzyiguanidine-thallium
scans . The interpretation by the observers was concordant
in 28 (93%) of 30 cases as to the presence or absence of
regional cardiac sympathetic denervation (that is, 1-123-
MIBG-thalliurn mismatch)
. In Patient I the final interpreta-
tion was minimal sympathetic denervation, whereas in Pa-
tient 30 the 1-123-MIBG scan was considered to be normal .
Twelve (67%) of the 18 Group I patients had regional
cardiac sympathetic denervation demonstrated by 1-123-
MIBG scans compared with only 1 (8%) of 12 of the Group
11 patients (p = 0 .002, Fig
. 2 and 3) . The myocardial areas
showing regional cardiac sympathetic denervation were in-
ferior (n 5), inferoapical (n = 3), postetolateral (n = 1),
lateral (n 1), anteroseptal (n = 2), apical (n = 1) and
anterolateral (n = 1) (Fig . 4)
. Two of the 12 patients from
Group I had sympathetic denervation involving more than
one area . Patient 28 from Group 11 had inferior regional
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TL 201
septum
1-123-MOO
Von 2. Short-axis (A) and horizontal long-axis (B) thallium-201
(TL 201) and iodine-123-metaiodobenzylguanidine (I-123-MIBG)
images from Patient 10 with left ventricular hypertrophy and mono-
morphic sustained ventricular tachycardia . Note the decreased
inferior and lateral uptake (arrows) of I-123-MIBG compared with
uptake on thallium-201 imaging consistent with sympathetic dener-
Vadon .
cardiac sympathetic denervation . This patient had hypertro-
phic cardiomyopathy with a family history of sudden cardiac
death and on clinical follow-up, he had unexplained syn-
cope.
Eketrophysiologic testing . Electrophysiologic testing in-
duced ventricular tachycardia in 16 of the 18 patients from
Group I and in none of the 4 patients from Group II (Table
1). Specifically, 10 patients had inducible sustained mow-
MKWPhR; ventricular tachycardia, 4 had nonsustained mono-
Fi4vn 3. Short-axis thallium-201 (TL 201) and iodine-123-
metaiodobenzy1guanidine (I-123-MIBG) images from Patient 4 with
a structurally normal heart and nonsustained ventricular tachycar-
dia. Note the decreased inferior uptake (arrows) of 1-123-MIBG
imaging compared with normal uptake on thallium-201 imaging,
consistent with sympathetic denervation .
apex
TL 201
septum
1-125MMO
lateral
lateral
septa
anterior
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Figure 4. Schematic of the left ventricle demonstrating superim-
posed short-axis slices from the apex to the base . The numbers
indicate the distribution of the 14 areas of sympathetic denervation
for the 12 patients with ventricular tachyarrhythmiaG . See text for
discussion .
morphic ventricular tachycardia, I had inducible polymor-
phic ventricular tachycardia, and I had inducible ventricular
flutter. In Patients 2, 5 and 17, ventricular tachycardia was
inducible only after infusion of isoproterenol . In Patient 10
ventricular tachycardia occurred spontaneously after isopro-
terenol infusion. Ten (63%) of 16 patients with inducible
ventricular tachycardia had sympathetic denervation com-
pared with 2 (33%) of 6 patients in whom ventricular
tachycardia was not inducible (p = NS) .
Patients with a structurally normal heart . Five (55%) of
nine patients with a structurally normal heart in Group I had
regional cardiac sympathetic denervation . None of the nine
patients with a structurally normal heart in Group II had
regional cardiac sympathetic denervation (p = 0.029) . One of
the two patients in Group I with a long QT interval had
regional cardiac sympathetic denervation in the anteroseptal
wall .
Ventricular tachycardia focus versus area of denervation.
Five patients underwent successful radiofrequency ablation
of ventricular tachycardia . Patients 2 and 7 did not have
evidence for sympathetic denervation . The sites of the
ventricular tachycardia focus and the sites of sympathetic
denervation in the other three patients are shown in Figure 5 .
Patients 1, 5 and 12 had evidence for sympathetic denerva-
tion in the left ventricle while the ventricular tachycardia
focus was ablated in the right ventricular outflow tract . It is
possible that Patient 1 had sympathetic denervation at or
near the area of the ventricular tachycardia ablation site .
However, because sympathetic scintigraphy of the right
ventricle was not performed, it is unknown whether any of
the five patients also had sympathetic denervation involving
the right ventricle. Patient 12 had recurrent ventricular
tachycardia with a right bundle branch block configuration
within 2 months of successful radiofrequency ablation for
right ventricular outflow tract tachycardia .
JACC Vol, 22, No . 5
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a) Patient 1
0 Antes.-:or
RV
Swum
b) Patient 5
C) Patient 12
RV
Figure S. Schematics representing locations of successful ventricu-
lar tachycardia radiofrequency ablation and areas of sympathetic
denervation for three patients . Superimposed short-axis slices of the
left ventricle are shown with the anterior and posterior right
ventricular (RV) walls
. The black circles represent areas where
radiofrequency ablation eliminated ventricular tachycardia, and the
lightened areas represent sympathetic denervation within the left
ventricle. In Patient 1, sympathetic denervation was in the an-
teroseptal region in the left ventricle adjacent to the right ventricular
site of radiofrequency ablation . In Patient 5, it was in the anterolat-
eral left ventricle remote from the radiolrequency ablation site in the
right ventricular anterior wall . In Patient 12, it was in the inferoap-
ical left ventricle remote from the radiofrequency ablation site ;n the
right ventricular outflow tract .
Discussion
Major observations . We believe that our study is the first
to demonstrate abnormalities in cardiac sympathetic func-
tion detected by 1-123-MIBG scintigraphy in patients with-
out coronary artery disease who had ventricular tachycar-
dia. The abnormal sympathetic scintigraphic findings are
probably due to regional cardiac sympathetic denervation,
as has been shown in animal and human studies (19,32) .
However, it is possible that the 1-123-MIBG defects may be
a more sensitive marker of epicardial myocardial injury that
is not detectable by conventional imaging modalities . The
finding of I-123-MIBG defects in patients with an apparently
structurally normal heart indicates that these patients actu-
ally do not have a structurally normal heart but, rather, have
evidence suggestive of cardiac sympathetic dysfunction .
Whether this sympathetic dysfunction is a result of a neu-
ropathy or other myopathic processes and whether its pres-
ence is important to the genesis of ventricular tachycardia
cannot be established from this study .
Role of cardiac sympathetic innervation . The human ven-
tricle is profusely innervated with sympathetic fibers that
modulate the electrophysiologic properties of the specialized
RV
cl'~
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and working fibers (33) . Enhanced sympathetic tone or
reduced parasympathetic tone, inferred by loss of sinus
cycle length variability or reduced baroreceptor sensitivity,
has been demonstrated to be associated with increased
incidence of sudden cardiac death after myocardial infarc-
tion (34-38) .
It is now well established in dogs (7-10,18,19) and hu-
mans (20-22) that myocardial infarction causes regional
areas of sympathetic denervation
. These denervation sites
subsequently exhibit denervation supersensitivity that is
manifested by an exaggerated electrophysiologic response to
circulating catecholamines (1 1, 12). Dogs with regional car-
diac sympathetic denervation and sympathetic supersensi-
tivity are more likely to have inducible ventricular fibrillation
that ,can be prevented by propranolol (12). The correlation of
regional cardiac sympathetic denervation with ventricular
arrhythmias in humans has also been demonstrated, al-
though intravenous beta-adrenergic blockade failed to pre-
vent induction of ventricular tachycardia (20) . We have
hypothesized that patients with coronary artery disease can
develop regional cardiac sympathetic denervation and sym-
pathetic supersensitivity after episodes of myocardial infarc-
tion that, in the presence of increased cardiac sympathetic
activity, create heterogeneous ventricular excitation and
repolarization patterns that can cause ventricular arrhyth-
mias ON Consistent with this hypothesis is the finding of an
increase in cardiac sympathetic activity documented by
excessive cardiac norepinephrine overflow in patients who
have survived an aborted episode of sudden cardiac death
(39) . Whether this hypothesis is more applicable to the origin
of less organized rhythms such as ventricular fibrillation
compared with ventricular tachycardia is not known. Nev-
ertheless, the beneficial effects of beta adrenoceptor block-
ers on cardiac death in patients after myocardial infarction
may, in part, be due to blocking the supersensitive response
to riorepinephrine and eliminating the electrophysiologic
heterogeneity .
Any damage to the myr .ardium should be capable of
interrupting neural axons, creating areas of sympathetic (and
vagal) denervation followed by denervation supersensitivity .
Abnormal 1-123-MIBG patterns have been found in patients
with dilated cardiomyopathy (23,24) . Prior studies in hyper-
tensive rats (40) have demonstrated intramyocardial intersti-
tial fibrosis and microscopic scarring; therefore, it is not
surprising that I-123-MIBG defects would be observed in
patients with left ventricular hypertrophy from hyperten-
sion . However, there are no apparent reasons for the pa-
tients without structural heart disease to have regional
cardiac sympathetic denervation . Obviously, it is possible
that they do have structural damage that is not apparent
using the relatively gross clinical tests available . Biopsies
were not routinely obtained in these patients, and they might
have revealed cellular abnormalities. Whatever the mecha-
nism, in this study there was an increased prevalence of
focal I-123-MIBG defects in patients with ventricular ar-
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rhythmias compared with the control group . This increased
prevalence of focal I-123-MIBG defects among patients with
ventricular tachycardia was particularly noteworthy in the
subgroup of patients with structurally normal hearts .
The presence of regional cardiac sympathetic denervation
in patients without coronary artery disease may be arrhyth-
mogenic by the same mechanisms proposed for patients with
coronary artery disease, as noted previously . The need for
catecholamine infusion to initiate ventricular tachycardia
during electrophysiologic testing, the clinical benefits of beta
adrenoceptor or calcium channel blockade and precipitation
of ventricular tachycardia by exercise all support the impor-
tance of sympathetic stimulation . However, there were six
patients in Group I with ventricular tachycardia who had
normal cardiac sympathetic scintigraphy. Therefore, it is
obvious that regional cardiac sympathetic denervation de-
tected by 1 .123-MIBG scintigraphy may not play a role in the
genesis of ventricular tachycardia in some patients without
coronary artery disease . It is still possible that these patients
have abnormalities in sympathetic innervation, function or
have response not noted on 1 .123-MIBG scintigraphy . For
example, our technique of I-123-MIBG scintigraphy did not
examine abnormalities in right ventricular sympathetic in-
nervation. Consistent with this notion of the importance of
the sympathetic nervous system despite normal 1-123-MIBG
scintigraphy was the observation that two patients with
normal I-123-MIBG scintigrams had inducible ventricular
tachycardia only after isoproterenol infusion .
Sympathetic denervation and ventricular tachycardia fo-
cus. Of the five patients who underwent electrophysiologic
mapping to determine the site of the ventricular tachycardia
focus before radiofrequency ablation, two did not have
regional cardiac sympathetic denervation, whereas two oth-
ers had sympathetic denervation in areas remote from where
the tachycardia was ablated . In the fifth patient, the area of
regional cardiac sympathetic denervation was adjacent to
the right ventricular site of ablation . Therefore, of these five
patients sympathetic denervation was present adjacent to
the arrhythm nic focus in only one . Because the ventric-
ular tachycardia was localized to and ablated in the right
ventricle, and because sympathetic scintigraphy was not
obtained on the right ventricle, we cannot exclude the
possibility that a thallium/1-123-MIBG mismatch was also
present in the right ventricle . This is an area for future study .
It is also possible that areas of sympathetic denervation
modulate the reentrant pathways required for the ventricular
tachycardia rather than its site of origin (41) . Finally, it is
possible that the presence of sympathetic denervation is
merely a marker for an abnormal ventricle and is unrelated
to the genesis of ventricular tachyarrhythmias .
Iodint-123-nietalodobenzylguanidine scintigraphy, Io-
dine- 123-metaiodobenzylguanidine scintigraphy in conjunc-
tion with thallium scintigraphy (at rest or during redistribu-
tion scans) can be used to detect mismatches between both
scans, suggestive of sympathetic denervation . In patients
with coronary artery disease, the concordance of interpre-
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tations by observers blinded to patient data was 100%v
(19) .
In the present study, the concordance was also high (93%) .
One case of discordance was due to the presence of a small
apical defect on the I-123-MIBG scintigram . Defects from
normal apical thinning, so-called keyhole defect, are recog-
nized in thallium scintigraphy ; their occurrence as a normal
phenomenon in I-123-MIBG scintigraphy may be secondary
to the decrease in myocardial norepinephrine concentrations
in the apex compared with the base (42,43) or just a result of
normal myocardial apical thinning .
In this study, only 1 (8%) of 12 patients without ventric-
ular arrhythmias had evidence of sympathetic denervation ;
this patient had hypertrophic cardiomyopathy and a family
history of sudden cardiac death. During the follow-up pe-
riod, this patient experienced syncope but did not undergo
electrophysiologic testing . None of the nine control patients
with a structurally normal heart had sympathetic denerva-
tion .
No patient in the control group had dilated cardiomyop-
athy. Prior studies (23,24) on patients with dilated cardiomy-
opathy indicated that 1-123-MIBG uptake was directly re-
lated to left ventricular ejection fraction . However, these
studies did not comment on the presence of ventricular
arrhythmias in those patients who underwent sympathetic
scintigraphy . Although the presence of 1-123-MIBG defects
may be a nonspecific finding, in patients with idiopathic
dilated cardiomyopathy the presence of regional cardiac
sympathetic denervation detectable by 1-123-MIBG was a
specific finding in patients with a structurally normal heart,
usually limited to those with documented ventricular ar-
rhythmias .
Wilber et al. (44) recently demonstrated the results of
1-123-MIBG scans perform~ ;ai in ivc peal cnLs I to 4 months
after radiofrequency ablation of adenosine-sensitive ventric-
ular tachycardia. Four patients had normal scan results,
whereas one patient had diffusely diminished uptake of
I-123-MIBG. The difference in findings between our report
and that of Wilber et al . (44) is probably due to differences in
study patients and in timing of I-123-MIBG scintigraphy . In
our unselected patients with different ventricular arrhyth-
mias, various mechanisms were responsible for their ven-
tricular tachycardias. Furthermore, I-123-MIBC scans were
performed at the time patients presented to our institution in
our study, whereas in the study of Wilber et al. (44) the scans
were performed I to 4 months after radiofrequency ablation .
The long QT syndrome. Two patients in Group I had a
long QT interval . III one patient (mentioned in a prior report
(201), MIBG scintigraphy was normal, but regional cardiac
sympathetic denervation was demonstrated in the other .
Both of these patients had a structurally normal heart . The
long QT syndrome has been attributed to abnormal sympa-
thetic innervation, possibly with increased left-sided versus
decreased right-sided sympathetic stimulation (45), although
the pathogenesis is not entirely clear (46) . Abnormalities in
MIBG scintigraphy have been found in some patients with
the long QT syndrome (25) .
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Sympathetic denervation and electrophysiologic testing .
Inducibility of ventricular tachycardia at electrophysiologic
study was not significantly correlated with the presence of
sympathetic denervation . although there was a trend toward
this correlation. The small number of patients may have
been insufficient to reveal a significant difference between
those with and without tachycardia inducibility . However,
the lack of correlation may also be explained by the de-
creased reliability of electrophysiologic testing in inducing
ventricular tachycardia in patients without than in patients
with coronary artery disease (47) .
Limitations. In this report sympathetic denervation was
diagnosed using 1-123-scintigraphy . Iodine-I23-labeled me-
taiodobenzylguanidine is taken up by postganglionic sympa-
thetic neurons by the same uptake mechanism used for
norepinephrine. Therefore, one could argue that an 1-123-
MIBG defect represents failure of uptake and not truly
sympathetic denervation . Furthermore, because we per-
formed 1-123-MIBG scintigraphy 2 to 4 h after injection of
the tracer, it is also possible that MIBG defects represent
normal uptake with enhanced release of MIBG, which also
may not represent true sympathetic denervation (48) . Be-
cause we did not perform 1-123-MIBG scans immediately
after injection, we do not know whether these patients would
have had early uptake of MIBG . Studies in patients after
acute myocardial infarction (23) and with dilated cardiomy-
opathy (21) have revealed that initial 1-123-MIBG scans
demonstrate significantly more MIBG uptake than is seen on
delayed imaging. This initial uptake was thought to be due to
nonspecific uptake (28,49), although more recently published
data suggest that early nonspecific MIBG uptake (uptake 2)
in humans is not significant (48) .
Nevertheless, the correlation of sympathetic denervation
by electrophysiologic testing to defects on 1 .. 123-MIBG
scintigraphy has been demonstrated in the dog model (19)
and suggests that focal MIBG defects result from regional
adrenergic dysfunction rather than a global process such as
enhanced turnover of catecholamines . At present, the exact
mechanism by which regional adrenergic dysfunction pro-
duces focal MIBG defects is unclear . Further confirmatory
data have been provided by Calkins and colleagues (32), who
demonstrated a correlation between sympathetic denerva-
tion by refractory period responses and sympathetic defects
detected by positron emission tomography using a different
neurotransmitter (C-11 hydroxyephedrine), an agent that
shares the same uptake mechanism as 1-123-MIBG . These
studies (19,32) suggest that scintigraphic evidence of de-
creased localization of norepinephrine analogues (1-123-
MIBG or C-11 hydroxyephedrine) represents sympathetic
denervation . With the present state of the art, it is difficult to
prove in humans the presence of regional cardiac sympa-
thetic denervation by applying techniques that we have used
in dogs, such as sympathetic nerve stimulation and norepi-
nephrine infusion while measuring effective refractory pe-
riod responses at multiple left ventricular sites . Accurate
identification of stimulation sites to matched areas of dener-
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vation by I- I 23-M 1BG scintigraphy is difficult. Furthermore,
we believed that there was no justification for obtaining
myocardial biopsy specimens to assess norepinephrine myo-
cardial concentration in denervated areas .
The mean age of the control group in this study was
significantly less than that of the study group ; however, the
control group included three patients between 11 and 19
years old from one family with hypertrophic cardiomyopa-
thy. Although it is possible that regional cardiac sympathetic
denervation occurs with the aging process, there was great
overlap among Fges in both groups of patients (with and
without denervation) . Furthermore, in the subgroup of pa-
tients with a structurally normal heart there was no signifi-
cant difference between ages in the study and control
groups . Patients as young as 19 years demonstrated regional
cardiac sympathetic denervation, whereas patients as old as
66 years had normal 1-123-MIBG scans . Thus, it does not
appeal- that sympathetic denervation is merely an aging
phenomenon .
Another limitation may be that the spectrum of cardiac
diseases present between both groups was different, How-
ever, the findings of this study were still valid when compar-
ing the subgroup of patients with structurally normal hearts .
The comparison of the areas of sympathetic denervation
with the sites of origin of ventricular tachycardia was limited
by comparisons of fluoroscopic images with SPECT scans .
Some patients may have had right ventricular regional
sympathetic denervation that was not detectable by our
standard SPECT scanning techniques .
In addition, three patients had 1-123-MIBG scintigraphy
after radiofrequency ablation . However, one of these pa-
tients had a normal I- 123-MIBG scinfigiain after receiving 28
radiofrequency applications, whereas another patient had
sympathetic denervation at a site remote from the ablation .
Other investigators failed to find focal MIBG defects in
patients imaged I to 4 months after radiofrequency ablation
of ventricular tachycardia (44) . Although we cannot exclude
an abnormal 1-123-MIBG scintigram resulting from radiofre-
quency ablation, it is unlikely because of the findings from
the two patients just described and because radiofrequency
ablation causes limited subendocardial lesions while sympa-
thetic nerves traverse through the subepicardium .
Conclusions . We have described abnormalities in sympa-
thetic innervation of the human heart in patients with ven-
tricular arrhythmias in the absence of coronary artery dis-
ease and, for the first time, in patients with an apparently
structurally normal heart . In some of the patients with
ventricular tachycardia, the defects seen on I-123-MIBG
scintigraphy were the only detectable structural cardiac
abnormalities. The findings from this study indicate that
regional cardiac sympathetic denervation is present in many
patients with ventricular tachycardia who do not have cor-
onary artery disease, including patients with a structurally
normal heart. The presence of regional cardiac sympathetic
denervation may play a role in arrhythmogenesis in patients
without apparent heart disease or, at the very least, may be
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a marker for cardiac abnormalities not apparent by conven-
tional testing .
We thank Patricia G
. Booher, BA for her outstanding administrative assis-
tance in this study .
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